Melissa A. Kelly Behrs
Corporate Officer/Principal at GERON CORPORATION
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Scarlett | M | 73 | 13 years | |
| Andrew Grethlein | M | 59 | 12 years | |
| V. Lawlis | M | 72 | 12 years | |
| Susan Molineaux | M | 70 | 12 years | |
| Gaurav Aggarwal | M | 51 | 1 years | |
| John McDonald | M | 63 | 2 years | |
| Scott Samuels | M | 54 | - | |
| Robert Spiegel | M | 73 | 14 years | |
| Elizabeth O'Farrell | F | 59 | 5 years | |
| Dawn Bir | F | 53 | 5 years | |
| Michelle Robertson | F | 57 | 1 years | |
| Aron Feingold | M | - | 2 years | |
| Anil Kapur | M | 54 | 5 years | |
| Edward E. Koval | M | 62 | 3 years | |
| Shannon Odam | F | - | 5 years | |
| Faye Feller | M | 42 | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Greenwood | M | 72 | 16 years | |
| Olivia Bloom | F | 55 | 29 years | |
| Leonard Patrick Gage | M | 81 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 9 years |
| Ho Young Huh | M | 54 | 8 years | |
| David J. Earp | M | 59 | 13 years | |
| Thomas D. Kiley | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 23 years |
| Alexander E. Barkas | M | 76 | 19 years | |
| David Karpf | M | 69 | - | |
| Craig Parker | M | 63 | 2 years | |
| Thomas B. Okarma | M | 78 | 13 years | |
| Karin Eastham | F | 74 | 14 years | |
| Philip D. Reilly | M | - | - | |
| Thomas Hofstaetter | M | 76 | 5 years | |
| Edward V. Fritzky | M | 73 | 15 years | |
| Stephen N. Rosenfield | M | 74 | - | |
| Fabio M. Benedetti | M | 58 | - | |
| Melanie I. Nallicheri | F | 56 | 2 years | |
| Adelene Perkins | F | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 years |
| Ralph Brandenberger | M | 55 | 11 years | |
| Aleksandra Rizo | M | 49 | 3 years | |
| John W. Loewy | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| John L. Knopf | M | 71 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 16 years |
| Steve Kelsey | M | 63 | - | |
| Jennifer A. Smith | M | - | 3 years | |
| Michael F. Jarvis | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 years |
| Edward D. Wirth | M | 59 | 7 years | |
| Gary Hattersley | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 years |
| Kirk Trisler | M | 64 | 3 years | |
| Thomas Spitznagel | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Sergei Gryaznov | M | 64 | 15 years | |
| Lynn M. Bodarky | F | 58 | 2 years | |
| Hassan Movahhed | M | - | - | |
| Patrick Zenner | M | 77 | 9 years | |
| John P. Walker | M | 75 | 11 years | |
| Stephen Albert Martin | M | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Charles Homcy | M | 75 | - | |
| Garen Bohlin | M | 76 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 14 years |
| Karen Dawes | F | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Alan Colowick | M | 61 | 2 years | |
| Graham Cooper | M | 54 | - | |
| Katharine E. Spink | M | 49 | - | |
| Gabriel Schmergel | M | 83 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 15 years |
| R. Greer | M | 65 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 6 years |
| Daniel Bradbury | M | 62 | 7 years | |
| Camille Bedrosian | M | 71 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Ronald Eastman | M | 71 | 6 years | |
| Jane S. Lebkowski | M | 68 | 13 years | |
| David L. Berstein | M | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Richard Shea | M | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 years |
| William D. Stempel | M | - | 3 years | |
| Robert H. Tidwell | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| James E. Vath | M | 62 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 years |
| Xiao Lin Wang | M | 53 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 69 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Melissa A. Kelly Behrs
- Personal Network
